In this regard, Stock et al. 12 recently demonstrated that the initial production of GM-CSF by cardiac fibroblasts primes cardiac inflammation in CAWS-induced vasculitis, and GM-CSF blockade markedly improves inflammatory status. This evidence concerns the gene CSF2 and vasculitis.